Biopartnering Seminar Series - Biosimilars and the Patent Landscape in Canada

Geoffrey Mowatt
Tuesday, February 23, 2016 - 6:30pm

Tuesday, February 23, 2016, 6:30pm.
Room 120, Instructional Building.

Guest Speaker: Geoffrey D. Mowatt, Partner, Dimock Stratton LLP

Biosimilars and the Patent Landscape in Canada

In 2010, Health Canada provided an approval pathway for biosimilars in Canada—a rapidly growing and emerging segment in the global biopharmaceutical sphere. While the pathway has been clarified, biosimilar approval by Health Canada and adoption by physicians still faces various hurdles, such as indication extrapolation and nonproprietary naming concerns. Similar to the pathway for small molecule generics, biosimilar sponsors are required to address innovator patents for the biologic drug used as a reference product before market entry. While only two biosimilars have been approved for marketing in Canada since that time, biosimilar litigation is already underway with a recent decision on the first biosimilar (filgrastim) addressed under the Patented Medicines (Notice of Compliance) Regulations. This and other decisions in the near future will help frame the future landscape for biosimilar patent litigation in Canada. 

About the speaker: 

Geoff is a partner at the law firm Dimock Stratton LLP in Toronto. His practice includes all areas of intellectual property law, with a focus on patent litigation—including pharmaceutical litigation under the Patented Medicines (Notice of Compliance) Regulations. Geoff is also a registered patent agent and trademark agent, and has been Certified by the Law Society as a Specialist in Patent Law. He has experience in all aspects of intellectual property litigation, ranging from pre-litigation opinions to appearing before the Ontario Court, Federal Court, and Federal Court of Appeal. He has worked with counsel in other jurisdictions, including the United States, Europe and Australia, to co-ordinate the Canadian part of multi-jurisdictional lawsuits. Geoff is the Chair of the Canadian Bar Association Biotechnology Committee and currently sits on the Ontario Bar Association Civil Litigation Executive. He is also a member of the American Intellectual Property Law Association, the Toronto Intellectual Property Group, and an Associate of the Intellectual Property Institute of Canada. Geoff received his LL.B. from Osgoode Hall Law School and holds a M.Sc. from UofT focussing on geochemistry and computer modelling.

All welcome! Light refreshments served at 6:00pm.

This seminar is part of the Biopartnering Seminar Series, offered by the Master of Biotechnology Program.